Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Circadian Rhythm of Blood Lactate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01303848
Recruitment Status : Completed
First Posted : February 25, 2011
Last Update Posted : May 2, 2012
Sponsor:
Collaborator:
State University of New York - Downstate Medical Center
Information provided by (Responsible Party):
Axel Schlitt, Martin-Luther-Universität Halle-Wittenberg

Brief Summary:
To elucidate whether blood lactate, lipid transfer proteins and PPARs/CLOCK/Bal1 have a circadian rhythm

Condition or disease Intervention/treatment
Healthy Other: Blood Sampling

Detailed Description:
Blood will be drawn fasting and then every hour over a period of 24 hours in 30 healthy probands.

Layout table for study information
Study Type : Observational
Actual Enrollment : 30 participants
Time Perspective: Prospective
Official Title: Circadian Rhythm of Blood Lactate, Lipid Transferproteins and Genetic Markers (PPARs, CLOCK, Bmal1)
Study Start Date : February 2011
Actual Primary Completion Date : December 2011
Actual Study Completion Date : May 2012

Group/Cohort Intervention/treatment
Healthy probands
Healthy probands, age between 18 and 40 years
Other: Blood Sampling
Blood Sampling over 24 hours




Primary Outcome Measures :
  1. Circadian rhythm of blood lactate [ Time Frame: 5 months ]
    Blood samples


Secondary Outcome Measures :
  1. Circadian rhythm of Lipid transfer proteins [ Time Frame: 5 months ]
    Blood

  2. Circadian rhythm of PPARs, CLOCK and Bal1 [ Time Frame: 5 months ]
    Blood



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
30 healthy probands
Criteria

Inclusion Criteria:

  • Age between 18 and 40 years old

Exclusion Criteria:

  • Inability/unwilling to give written informed consent
  • Chronic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01303848


Locations
Layout table for location information
Germany
University Clinic Halle, Martin Luther-University Halle-Wittenberg
Halle (Saale), Germany, 06120
Sponsors and Collaborators
Martin-Luther-Universität Halle-Wittenberg
State University of New York - Downstate Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Axel Schlitt, MD Department of Medicine III, University Clinic Halle, Martin Luther-University Halle-Wittenberg
Layout table for additonal information
Responsible Party: Axel Schlitt, PD Dr. med. habil., Martin-Luther-Universität Halle-Wittenberg
ClinicalTrials.gov Identifier: NCT01303848    
Other Study ID Numbers: UKH2011Sport1
First Posted: February 25, 2011    Key Record Dates
Last Update Posted: May 2, 2012
Last Verified: May 2012
Keywords provided by Axel Schlitt, Martin-Luther-Universität Halle-Wittenberg:
Blood lactate
Lipid transfer proteins
Lactate
PLTP
CETP
PPARs
CLOCk
Bal1